Outset Medical Reports Q1 Results with Record Gross Margin and Reduced Net Loss
OM sits 35% above its 52-week low of $3.
Summary
Outset Medical, Inc. reported first-quarter 2026 financial results, highlighting a record gross margin of 43.4% and a significant reduction in net loss, alongside a strong cash position and reiterated full-year guidance.
Key Events · Earnings and Guidance · OM
-
Record Gross Margin Achieved
Gross margin expanded by over 600 basis points to a record 43.4% (43.8% non-GAAP), driven by strong product and service gross margins.
-
Net Loss Significantly Reduced
Net loss decreased to $19.0 million from $25.8 million in the prior-year period, reflecting improved operational efficiency.
-
Strong Cash Position and Reduced Cash Burn
The company ended the quarter with $161 million in cash, cash equivalents, and short-term investments, with net cash used of $12 million, less than previously forecasted.
-
Revenue Decline and Reaffirmed Guidance
Net revenue decreased 6% to $27.9 million, but the company reiterated its full-year 2026 revenue guidance of $125 million to $130 million and non-GAAP gross margin guidance.
Analysis · OM · Industrial Applications And Services
Despite a 6% decline in net revenue, Outset Medical demonstrated strong operational execution by expanding its gross margin by over 600 basis points to a record 43.4%. The company also significantly reduced its net loss and managed cash burn better than forecasted, ending the quarter with a robust $161 million in cash. These improvements in profitability and cash management are critical for a company of this size and indicate progress towards its path to profitability, reinforcing investor confidence in its reiterated full-year guidance.
At the time of this filing, OM was trading at $4.06 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $86.6M. The 52-week trading range was $3.00 to $21.98. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.